Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-35,577
Closed -$547K – 129
2025
Q3
$547K Hold
35,577
– – 0.03% 102
2025
Q2
$559K Buy
+35,577
New +$539K 0.02% 100
2023
Q1
– Sell
-154,313
Closed -$2.65M – 130
2022
Q4
$2.65M Buy
+154,313
New +$2.74M 0.47% 56

Other funds holding RXO

Clearline Capital's RXO Position: Q4 2025 in Review

Clearline Capital sold out of RXO (RXO) in Q4 2025, closing a stake of 35,577 shares — an estimated $547K sold.

Clearline Capital first reported a position in RXO in Q4 2022 and held it in 3 quarters. The position peaked at $2.65M in Q4 2022. 269 funds tracked by Wall St. Rank hold RXO as of Q4 2025.

  • Clearline Capital reported no remaining RXO position as of Q4 2025 after selling out during the quarter.
  • Clearline Capital sold 35,577 RXO shares in Q4 2025, an estimated $547K.
  • Clearline Capital first reported a position in RXO in Q4 2022 and held it in 3 quarters.
  • Clearline Capital's RXO position peaked at $2.65M in Q4 2022.
  • 269 funds tracked by Wall St. Rank held RXO as of Q4 2025.

Based on Clearline Capital's 13F filing for Q4 2025, filed 17 Feb 2026.